Skip to main content
. 2019 Jan 16;8(1):e10807. doi: 10.2196/10807

Table 2.

Schedule of evaluations.

Evaluation Screen Entry Week(s) Month(s)

1 2 4 8 4 8 12 18 24
Documentation of acute HIV X a
Fiebig staging X
Financial screening X
History X
Physical examination X X X X X X X X X X
Adherence assessment X X X X X X X
Antiretroviral therapy (ART) initiated X
HIV-1/2 enzyme immunoassay fourth generation assay X
HIV-1 genotypic testing X
Urine analysis X
Complete blood count with differential and platelets X X X X X X X X
Liver function tests (ASTb, ALTc, GGTd) X X X X X X X X
Renal function tests (blood urea nitrogen, creatine) X X X X X X X X
T cell subsets X X X X X X X X
HIV-1 RNA PCRe quantitative X X X X X X X X
HIV-1 Western blot X X X X X X X
Hepatitis B and C panel X
Rapid plasma regain X
Gonorrhea/chlamydia PCR of urine, oropharynx, and rectum X
Cytomegalovirus PCR blood Xf Xf Xf Xf Xf Xf Xf Xf Xf Xf Xf
Pregnancy test Xg Xg Xg Xg Xg Xg Xg Xg Xg Xg
Reservoir study laboratories (mL) 30 10 10 10 10 30 10 30 10 30

aNot applicable.

bAST: aspartate aminotransferase.

cALT: alanine aminotransferase.

dGGT: gamma-glutamyl transferase.

ePCR: polymerase chain reaction.

fIf clinically suspected.

gWhenever pregnancy is suspected.